| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Azoulay Salomon serves as a Chief Medical Officer at MBX. Across recent SEC filings that breaks down to 0 buys and 4 sells. Those positions are worth an estimated $947K at current prices.
The biggest single holding is MBX (~$947K) as Chief Medical Officer. The recent filings there lean toward selling, a net 70,604 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 4, 2026 | MBX Mbx Biosciences, Inc. | Chief Medical Officer | Sell | 370 | $65.77 | $24,334.90 | -2.5% | - | - | |
| May 8, 2026 | MBX Mbx Biosciences, Inc. | Chief Medical Officer | Sale+OE10b5-1 | 70,003 | $38.36 | $2,685,514.90 | -82.6% | +63.8% | - | |
| May 6, 2026 | MBX Mbx Biosciences, Inc. | Chief Medical Officer | Sell | 231 | $29.54 | $6,823.74 | -1.5% | +120.1% | - |